Relapses of childhood anaplastic large-cell lymphoma: Treatment results in a series of 41 children - A report from the French Society of Pediatric Oncology

Annals of Oncology

Volumn 11, Issue 1, 2000, Pages 53-58

  Brugieres L ^a   Quartier, P ^a   Le Deley, M C ^a   Pacquement, H ^b   Perel, Y ^c   Bergeron, C ^d   Schmitt, C ^e   Landmann, J ^f   Patte, C ^a   Terrier Lacombe, M J ^a   Delsol, G ^g   Hartmann, O ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT CURIE   (France)

^c HÔPITAL PELLEGRIN   (France)

^d CENTRE LÉON BÉRARD   (France)

^e HÔPITAL D ENFANTS   (France)

^f ARMAND TROUSSEAU HOSPITAL   (France)

^g CHU PURPAN   (France)

Author keywords

ABMT; Anaplastic large cell lymphoma; Children; Relapse; Vinblastine

Indexed keywords

BLEOMYCIN; CYTARABINE; LOMUSTINE; VINBLASTINE;

ADOLESCENT; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHILDHOOD CANCER; DRUG EFFICACY; FEMALE; HISTIOCYTIC LYMPHOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0033967199     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008352726155     Document Type: Article

References (39)

1. Murphy SB. Pediatric lymphomas: Recent advances and commentary on Ki-1-positive anaplastic large-cell lymphomas of childhood. Ann Oncol 1994 5: 31-3.
2. Wright D, McKeever P, Carter R. Childhood non-Hodgkin lymphomas in the United Kingdom: Findings from the UK Children's Cancer Study Group. J Clin Pathol 1997; 50: 128-34.
3. Chott A, Kaserer K, Augustin I et al. Ki-1-positive large-cell lymphoma. A clinicopathologic study of 41 cases. Am J Surg Pathol 1990; 14: 439-48.
4. Clavio M, Rossi E, Truini M et al. Anaplastic large-cell lymphoma: A clinicopathologic study of 53 patients. Leuk Lymph 1996; 22: 319-27.
5. Greer JP, Kinney MC, Collins RD et al. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 1991; 9: 539-47.
6. Shulman LN, Frisard B, Antin JH et al. Primary Ki-1 anaplastic large-cell lymphoma in adults: Clinical characteristics and therapeutic outcome. J Clin Oncol 1993; 11: 937-42.
7. Longo G, Federico M, Pieresca C et al. Anaplastic large-cell lymphoma (CD30+/Ki-1+). Analysis of 35 cases followed at GISL centres. Eur J Cancer 1995; 31A: 1763-7.
8. Zinzani PL, Bendandi M, Martelli M et al. Anaplastic large-cell lymphoma: Clinical and prognostic evaluation of 90 adult patients. J Clin Oncol 1996; 14: 955-62.
9. Fanin R, Silvestri F, Geromin A et al. Sequential intensive treatment with the F-MACHOP regimen (+/-radiotherapy) and autologous stem-cell transplantation for primary systemic CD30 (Ki-1)-positive anaplastic large-cell lymphoma in adults. Leuk Lymph 1997; 24: 369-77.
10. Tilly H, Gaulard P, Lepage E et al. Primary anaplastic large-cell lymphoma in adults: Clinical presentation, immunophenotype, and outcome. Blood 1997; 90: 3727-34.
11. Pileri S, Bocchia M, Baroni CD et al. Anaplastic large-cell lymphoma (CD30 +/Ki-1+): Results of a prospective clinicopathological study of 69 cases. Br J Haematol 1994; 86: 513-23.
12. Vecchi V, Burnelli R, Pileri S et al. Anaplastic large-cell lymphoma (Ki-1+/CD30+) in childhood. Med Pediatr Oncol 1993; 21: 402-10.
13. Reiter A, Schrappe M, Tiemann M et al. Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin Frankfurt Munster group studies. J Clin Oncol 1994; 12: 899-908.
14. Massimino M, Gasparini M, Giardini R. Ki-1 (CD30) anaplastic large-cell lymphoma in children. Ann Oncol 1995; 6: 915-20.
15. Sandlund JT, Pui CH, Roberts WM et al. Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23;q35). Blood 1994; 84: 2467-71.
16. Gordon BG, Weisenburger DD, Sanger WG et al. Peripheral T-cell lymphoma in children and adolescents: Role of bone marrow transplantation. Leuk Lymph 1994; 14: 1-10.
17. Chakravarti V, Kamani NR, Bayever E et al. Bone marrow transplantation for childhood Ki-1 lymphoma. J Clin Oncol 1990; 8: 657-60.
18. De Vita F, Di Grazia M, Orditura M et al. Autologous bone marrow transplantation in Ki-1 lymphoma with poor prognosis. A case report. Recenti Prog Med 1994; 85: 278-81.
19. Reinhold U, Frick M, Fischer J et al. High-dose chemotherapy with autologous stem cell transplantation in a patient with a CD30+ anaplastic large cell lymphoma of the skin. Br J Dermatol 1996; 134: 811-3 (Letter).
20. Fanin R, Ruiz de Elvira M, Sperotto A et al. Autologous stem-cell transplantation for T-and null-cell CD-30 positive anaplastic large-cell lymphoma: Analysis of 64 adults and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT). BMT 1999; 23: 437-42.
21. Brugières L, Caillaud JM, Patte C et al. Malignant histiocytosis: Therapeutic results in 27 children treated with a single polychemotherapy regimen. Med Pediatr Oncol 1989; 17: 193-6.
22. Brugières L, Le Deley MC, Pacquement H et al. Anaplastic large-cell lymphoma in children: Analysis of 63 patients enrolled in two consecutive studies of the SFOP. Med Pediatr Oncol 1997; 29: 357.
23. Harris NL, Jaffe ES, Stein H et al. A Revised European American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
24. Benharroch D, Meguerian-Bedoyan Z, Lamant L et al. ALK-positive lymphoma: A single disease with a broad spectrum of morphology. Blood 1998; 91: 2076-84.
25. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
26. Gentet JC, Patte C, Quintana E et al. Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: A study of the French Society of Pediatric Oncology. J Clin Oncol 1990; 8: 661-5.
27. Ladenstein R, Pearce R, Hartmann O et al. High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt's lymphoma: A report from the European Lymphoma Bone Marrow Transplantation Registry. Blood 1997; 90: 2921-30.
28. Hartmann O, Pein F. Beaujean F et al. High-dose polychemotherapy with autologous bone marrow transplantation in children with relapsed lymphomas. J Clin Oncol 1984; 2: 979-85.
29. Avet-Loiseau H, Hartmann O, Valteau D et al. High-dose chemotherapy containing busulfan followed by bone marrow transplantation in 24 children with refractory or relapsed non-Hodgkin's lymphoma. BMT 1991; 8: 465-72.
30. Philip T, Hartmann O, Pinkerton R et al. Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first-line therapy: A report from the Société Française d'Oncologie Pédiatrique. Blood 1993; 81: 2003-6.
31. Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540-5.
32. Haioun C, Lepage E, Gisselbrecht C et al. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 1997; 15: 1131-7.
33. Caballero MD, Rubio V, Rifon J et al. BEAM chemotherapy followed by autologous stem-cell support in lymphoma patients: Analysis of efficacy, toxicity and prognostic factors. BMT 1997; 20: 451-8.
34. Armstrong JG, Dyke RW, Fouts PJ et al. Hodgkin's disease, carcinoma of the breast, and other tumor treated with vinblastine sulfate. Cancer Chemother Rep 1962: 18: 49-56.
35. Leoncini L, Del Vecchio M, Kraft R et al. Hodgkin's disease and CD30-positivr anaplastic large-cell lymphomas. A continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study. Am J Pathol 1990; 137: 1047-57.
36. Carter S, Livingston R. Single-agent therapy for Hodgkin's disease. Arch Intern Med 1973; 131: 377-87.
37. Warren R, Bender R, Norton L et al. The treatment of combination chemotherapy-resistant Hodgkin's disease with single-agent vinblastine. Am J Hematol 1978; 4: 47-55.
38. Little R, Wittles R. Longo D et al. Vinblastine for recurrent Hodgkin's disease following autologous bone marrow transplant. J Clin Oncol 1998; 16: 584-8.
39. Klener P, Donner L, Ort J. Use of vinblastine for maintenance therapy in malignant lymphomas. Neoplasma 1974; 21: 323-9.